Get early access to treatment options and help advance research for cancer and other diseases.
Follow one of our pre-made tracks below, or browse the full course library.
Six lecturers provide in-depth reviews of the federal FDA and other regulations and guidelines that govern all aspects of clinical and translational research on new drugs and biomedical devices.
In this series, we will discuss pharmacovigilance and safety reporting in clinical trials. Case studies are presented throughout the series.
In this session, we will discuss trends in drug development in 2017 and look at case studies that reflect these trends.
NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI
resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.